Anti-FKTN monoclonal antibody
Pre-made anti-FKTN monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to FKTN/FKTN products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP0852-Ab-1/ GM-Tg-hg-IP0852-Ab-2 | Anti-Human FKTN monoclonal antibody | Human |
GM-Tg-rg-IP0852-Ab-1/ GM-Tg-rg-IP0852-Ab-2 | Anti-Rat FKTN monoclonal antibody | Rat |
GM-Tg-mg-IP0852-Ab-1/ GM-Tg-mg-IP0852-Ab-2 | Anti-Mouse FKTN monoclonal antibody | Mouse |
GM-Tg-cynog-IP0852-Ab-1/ GM-Tg-cynog-IP0852-Ab-2 | Anti-Cynomolgus/ Rhesus macaque FKTN monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP0852-Ab-1/ GM-Tg-felg-IP0852-Ab-2 | Anti-Feline FKTN monoclonal antibody | Feline |
GM-Tg-cang-IP0852-Ab-1/ GM-Tg-cang-IP0852-Ab-2 | Anti-Canine FKTN monoclonal antibody | Canine |
GM-Tg-bovg-IP0852-Ab-1/ GM-Tg-bovg-IP0852-Ab-2 | Anti-Bovine FKTN monoclonal antibody | Bovine |
GM-Tg-equg-IP0852-Ab-1/ GM-Tg-equg-IP0852-Ab-2 | Anti-Equine FKTN monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-IP0852-Ab-1/ GM-Tg-hg-IP0852-Ab-2; GM-Tg-rg-IP0852-Ab-1/ GM-Tg-rg-IP0852-Ab-2; GM-Tg-mg-IP0852-Ab-1/ GM-Tg-mg-IP0852-Ab-2; GM-Tg-cynog-IP0852-Ab-1/ GM-Tg-cynog-IP0852-Ab-2; GM-Tg-felg-IP0852-Ab-1/ GM-Tg-felg-IP0852-Ab-2; GM-Tg-cang-IP0852-Ab-1/ GM-Tg-cang-IP0852-Ab-2; GM-Tg-bovg-IP0852-Ab-1/ GM-Tg-bovg-IP0852-Ab-2; GM-Tg-equg-IP0852-Ab-1/ GM-Tg-equg-IP0852-Ab-2 |
Products Name | Anti-FKTN monoclonal antibody |
Format | mab |
Target Name | FKTN |
Protein Sub-location | Introcelluar Protein |
Category of antibody | |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-FKTN monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-IP0852-Ag-1 | Recombinant multi-species FKTN/ CMD1X/ FCMD protein |
ORF Viral Vector | pGMLP001502 | human FKTN Lentivirus plasmid |
ORF Viral Vector | vGMLP001502 | human FKTN Lentivirus particle |
ORF Viral Vector | pGMLPm004849 | mouse Fktn Lentivirus plasmid |
ORF Viral Vector | vGMLPm004849 | mouse Fktn Lentivirus particle |
Target information
Target ID | GM-IP0852 |
Target Name | FKTN |
Gene ID | 2218,246179,362520,712201,481652,101084659,536891,100054199 |
Gene Symbol and Synonyms | CMD1X,D830030O17Rik,FCMD,FKTN,LGMD2M,LGMDR13,MDDGA4,MDDGB4,MDDGC4 |
Uniprot Accession | O75072 |
Uniprot Entry Name | FKTN_HUMAN |
Protein Sub-location | Introcelluar Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000106692 |
Target Classification | N/A |
The target: FKTN, gene name: FKTN, also named as CMD1X, FCMD, LGMD2M, LGMDR13, MDDGA4, MDDGB4, MDDGC4. The protein encoded by this gene is a putative transmembrane protein that is localized to the cis-Golgi compartment, where it may be involved in the glycosylation of alpha-dystroglycan in skeletal muscle. The encoded protein is thought to be a glycosyltransferase and could play a role in brain development. Defects in this gene are a cause of Fukuyama-type congenital muscular dystrophy (FCMD), Walker-Warburg syndrome (WWS), limb-girdle muscular dystrophy type 2M (LGMD2M), and dilated cardiomyopathy type 1X (CMD1X). Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Nov 2010].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.